Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Fetal Health Locus of Control and Maternal Anxiety in High-Risk Pregnancies

Official title: The Relationship Between Fetal Health Locus of Control Perceptions, Anxiety Levels, and Fetal Cardiotocography Parameters in High-Risk Pregnant Women

Run by Istanbul Training and Research Hospital · NCT07774936 · Data updated 2026-11-12

This study will see if a mom’s beliefs about what controls her baby’s health and her anxiety level relate to the baby’s heart patterns on routine fetal monitoring in high-risk pregnancies.

More High Risk Pregnancy trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment150 (estimated)
SponsorIstanbul Training and Research Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedApril 14, 2026
Main results expectedMay 2028
Study endsDecember 2028
Registry record updatedAugust 19, 2026
Trial IDNCT07774936 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are singleton pregnancies at 32 weeks or later with a high-risk condition, no psychiatric disorder or current psychiatric meds, and a routine NST planned at the Perinatology Outpatient Clinic.

Probably not a fit

Participants with fetal conditions affecting NST tracing or with psychiatric illness or medication use may not benefit from the study findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cross-sectional study will enroll women with high-risk pregnancies at 32 weeks of gestation or later who are undergoing a routine non-stress test (NST). Participants will complete the Fetal Health Locus of Control Scale and the Beck Anxiety Inventory on the same day as the NST. Fetal cardiotocography parameters, including baseline heart rate, accelerations, reactivity, and decelerations, will be assessed using FIGO-based criteria by an experienced investigator. The study aims to explore associations between FHLC dimensions, maternal anxiety, and NST findings, with secondary analyses considering sociodemographic factors. No interventions are being tested; the focus is on observational relationships in a single time point per participant.

Why it matters

Potential benefit: If successful, findings could help identify psychosocial factors linked to fetal monitoring patterns in high-risk pregnancies.

How similar studies have gone: Previous research has linked maternal anxiety and health beliefs to pregnancy-related outcomes, but this specific combination with FHLC and NST parameters is novel/less explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton pregnancy at 32 weeks of gestation or later
* Being followed for a high-risk pregnancy
* No known diagnosed psychiatric disorder and no current psychiatric medication use
* Absence of a fetal condition considered likely to affect the NST tracing
* Maternal age between 18 and 45 years

Exclusion Criteria:

* Gestational age below 32 weeks and/or multiple pregnancy
* Presence of a fetal condition considered likely to affect the NST tracing
* Acute maternal infection or an obstetric emergency
* Known diagnosed psychiatric disorder and/or current psychiatric medication use
* Maternal age below 18 years or above 45 years

Where it's running

  • Istanbul Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.